BioCentury
ARTICLE | Company News

metaGen GmbH, RNAx deal

March 31, 2003 8:00 AM UTC

Functional genomics company RNAx granted metaGen access to its RNA interference (RNAi) validation technology. metaGen will use the technology to validate cancer gene targets, and retains the rights to...